419 related articles for article (PubMed ID: 31698726)
1. The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma.
Handa H; Murakami Y; Ishihara R; Kimura-Masuda K; Masuda Y
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31698726
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance.
Puła A; Robak P; Robak T
Curr Med Chem; 2021 Oct; 28(33):6753-6772. PubMed ID: 33949926
[TBL] [Abstract][Full Text] [Related]
3. [Aberrant micro RNA and epigenetic network are associated with progression from MGUS to multiple myeloma].
Handa H
Rinsho Ketsueki; 2015 Aug; 56(8):981-8. PubMed ID: 26345556
[TBL] [Abstract][Full Text] [Related]
4. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.
Bi C; Chung TH; Huang G; Zhou J; Yan J; Ahmann GJ; Fonseca R; Chng WJ
Oncotarget; 2015 Sep; 6(28):26508-18. PubMed ID: 26164366
[TBL] [Abstract][Full Text] [Related]
6. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review.
Favier A; Rocher G; Larsen AK; Delangle R; Uzan C; Sabbah M; Castela M; Duval A; Mehats C; Canlorbe G
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33800944
[TBL] [Abstract][Full Text] [Related]
8. Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets.
Arif KMT; Elliott EK; Haupt LM; Griffiths LR
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050637
[TBL] [Abstract][Full Text] [Related]
9. OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.
Otmani K; Rouas R; Lewalle P
Front Immunol; 2022; 13():913951. PubMed ID: 36189271
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatment.
Fazi F; Blandino G
Microrna; 2013; 2(2):81. PubMed ID: 25070777
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA Silencing by DNA Methylation in Human Cancer: a Literature Analysis.
Strmsek Z; Kunej T
Noncoding RNA; 2015 Apr; 1(1):44-52. PubMed ID: 29861414
[TBL] [Abstract][Full Text] [Related]
12. Significance of miR-15a-5p and CNKSR3 as Novel Prognostic Biomarkers in Non-Small Cell Lung Cancer.
Ergun S; Güney S; Temiz E; Petrovic N; Gunes S
Anticancer Agents Med Chem; 2018; 18(12):1695-1701. PubMed ID: 30019650
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients.
Mjelle R; Dima SO; Bacalbasa N; Chawla K; Sorop A; Cucu D; Herlea V; Sætrom P; Popescu I
BMC Cancer; 2019 Oct; 19(1):1007. PubMed ID: 31660891
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
Hummel R; Hussey DJ; Haier J
Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
[TBL] [Abstract][Full Text] [Related]
15. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
Gunaratne PH
Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
[TBL] [Abstract][Full Text] [Related]
16. Aberrant microRNA expression in multiple myeloma.
Dimopoulos K; Gimsing P; Grønbæk K
Eur J Haematol; 2013 Aug; 91(2):95-105. PubMed ID: 23586898
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA epigenetic signatures in human disease.
Piletič K; Kunej T
Arch Toxicol; 2016 Oct; 90(10):2405-19. PubMed ID: 27557899
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
19. Role of CTCF in the regulation of microRNA expression.
Saito Y; Saito H
Front Genet; 2012; 3():186. PubMed ID: 23056006
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of microRNAs in cancer: an integrated review of literature.
Kunej T; Godnic I; Ferdin J; Horvat S; Dovc P; Calin GA
Mutat Res; 2011 Dec; 717(1-2):77-84. PubMed ID: 21420983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
